2018 Cardiovascular Grand Rounds Evaluation & Post Test-Enduring Materials Format: Medical Device Innovation

June 20, 2018- Evaluation & Post Test- CV GR, Medical Device Innovation
Presenter, Gary Gershony, MD, FACC, FSCI,
Estimated Time to complete the activity is 45 minutes. Activity and content expires: JUNE 20, 2021
Statement of disclosure: The planners and faculty for this activity have no relevant financial relationships with commercial interests. No others individuals involved in the planning or presentation of this activity have any relevant financial relationships with commercial interests to disclose.
Accreditation Statement: John Muir Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Credit Designation Statement: John Muir Health designates this enduring material for a maximum of one (.75) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Minimum level of achievement: Must score 75% correct on posttest and complete the statement of how you will improve your practice after participation is mandatory.
JMH Internet Policy: https://www.johnmuirhealth.com/website-privacy-policy1.html

Please complete and return this evaluation form in order to receive a maximum of .75 AMA PRA Category 1 Credit™ for this session

1. Physician Info

Physician First Name

Physician Last Name

2. Date of Completion? This question requires a valid date format of MM/DD/YYYY.

calendar

3. As a result of attending this CME activity, which of these do you plan to implement and/or change in your practice? *This question is required.

Space Cell	Definitely	Maybe	No Change
Understand the steps involved with innovating medical devices to address unmet clinical needs.
Understand the key role of the FDA in regulating new medical devices.
Understand the importance of collaboration between healthcare providers, regulators, industry and the investment community in order to achieve a robust innovation ecosystem.

4. Was there active participation in the case-discussions and of outcomes of cases shared?

5. Please list additional improvements or changes you plan to make as a result of attending this activity *This question is required.

6. Please list any barriers that you must overcome to implement your planned improvements or changes: 

7. Please REFLECT and relate a circumstance when information you received from a previous Clinical Conference has helped you in your practice

8. Comments Regarding this topic/speaker?

9. What topics would you like covered at future sessions?

10. Was their evidence of commercial bias in this session? 

If yes, please explain

11. The most important step in medical device innovation is identifying an unmet clinical need.

12. With respect to U.S. patent priority dates the most important is “first to invent.”

13. Passage of the 21st Century Cures Act has led to longer regulatory approval times.

14. Venture capital funding for early stage medical device companies has more than doubled in the past 10 years.